drugset / Trial / NCT06778460
Effect of Esketamine and Lidocaine on Postoperative Chronic Pain and Long-term Survival in Patients Undergoing Hepatectomy
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a further observation and follow-up of the patients enrolled in the registration number ChiCTR230007164430 to further evaluate the effect of long-term infusion of esketamine and lidocaine on postoperative chronic pain, long-term quality of life and survival rate in patients undergoing hepatectomy.
Timeline
- Start
- 2023-05-05
- Primary completion
- 2027-03-31
- Completion
- 2027-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 0.02 mg/kg | — |
| Subject | Lidocaine | Other / unclassified | 1 mg/kg | — |
| Background | Granisetron | Other / unclassified | 12 mg | — |
| Background | Sufentanil | Other / unclassified | 2 ug/kg | — |